Suppr超能文献

对转录后调控基因的化学调节剂进行高通量筛选。

High-throughput screening for chemical modulators of post-transcriptionally regulated genes.

作者信息

Sidarovich Viktoryia, Adami Valentina, Quattrone Alessandro

机构信息

Laboratory of Translational Genomics, Centre for Integrative Biology, University of Trento;

High Throughput Screening Core Facility, Centre for Integrative Biology, University of Trento.

出版信息

J Vis Exp. 2015 Mar 3(97):52568. doi: 10.3791/52568.

Abstract

Both transcriptional and post-transcriptional regulation have a profound impact on genes expression. However, commonly adopted cell-based screening assays focus on transcriptional regulation, being essentially aimed at the identification of promoter-targeting molecules. As a result, post-transcriptional mechanisms are largely uncovered by gene expression targeted drug development. Here we describe a cell-based assay aimed at investigating the role of the 3' untranslated region (3' UTR) in the modulation of the fate of its mRNA, and at identifying compounds able to modify it. The assay is based on the use of a luciferase reporter construct containing the 3' UTR of a gene of interest stably integrated into a disease-relevant cell line. The protocol is divided into two parts, with the initial focus on the primary screening aimed at the identification of molecules affecting luciferase activity after 24 hr of treatment. The second part of the protocol describes the counter-screening necessary to discriminate compounds modulating luciferase activity specifically through the 3' UTR. In addition to the detailed protocol and representative results, we provide important considerations about the assay development and the validation of the hit(s) on the endogenous target. The described cell-based reporter gene assay will allow scientists to identify molecules modulating protein levels via post-transcriptional mechanisms dependent on a 3' UTR.

摘要

转录调控和转录后调控都对基因表达有着深远影响。然而,常用的基于细胞的筛选测定法侧重于转录调控,其本质目标是鉴定靶向启动子的分子。因此,转录后机制在很大程度上未被针对基因表达的药物开发所揭示。在此,我们描述一种基于细胞的测定法,旨在研究3'非翻译区(3'UTR)在调节其mRNA命运中的作用,并鉴定能够修饰它的化合物。该测定法基于使用一种荧光素酶报告构建体,其包含稳定整合到疾病相关细胞系中的感兴趣基因的3'UTR。该方案分为两部分,最初重点是进行初步筛选,旨在鉴定在处理24小时后影响荧光素酶活性的分子。该方案的第二部分描述了进行反筛选的必要性,以区分通过3'UTR特异性调节荧光素酶活性的化合物。除了详细的方案和代表性结果外,我们还提供了关于测定法开发以及对内源靶点上命中物进行验证的重要考虑因素。所描述的基于细胞的报告基因测定法将使科学家能够鉴定通过依赖于3'UTR的转录后机制调节蛋白质水平的分子。

相似文献

4
The MYCN oncoprotein as a drug development target.作为药物开发靶点的MYCN癌蛋白。
Cancer Lett. 2003 Jul 18;197(1-2):125-30. doi: 10.1016/s0304-3835(03)00096-x.

本文引用的文献

3
Principles and properties of eukaryotic mRNPs.真核 mRNA 颗粒的原理和性质。
Mol Cell. 2014 May 22;54(4):547-58. doi: 10.1016/j.molcel.2014.04.033.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验